Biomedical subjects
P V Rocca
Publications and source records attributed to P V Rocca.
Systemic vasculitis--Part I. An approach to the patient.
Explore the source record for details and available documents.
Systemic vasculitis--Part II. Specific diseases.
Explore the source record for details and available documents.
Is anthrax the next Lyme disease?
Explore the source record for details and available documents.
The fading art of the physical examination.
Explore the source record for details and available documents.
When knowledge is bad.
Explore the source record for details and available documents.
A stroke is nothing to sneeze at.
Explore the source record for details and available documents.
Fibromyalgia: how disabling?
Explore the source record for details and available documents.
Our scientific past.
Explore the source record for details and available documents.
ACE inhibitor use for CHF in Delaware.
Explore the source record for details and available documents.
Yet another suggestion to improve quality of care.
Explore the source record for details and available documents.
May we please have an alternative to alternative medicine?
Explore the source record for details and available documents.
The concomitant expression of vasculitis and coagulopathy: synergy for marked tissue ischemia.
We describe 4 patients with coagulopathy and vasculitis that demonstrated marked tissue ischemia and necrosis. In the clinical setting of rapid evolution of vascular insufficiency, the possibility of combined vasculopathic processes should be considered. This is especially so in patients with underlying connective tissue disease such as systemic lupus erythematosus or rheumatoid arthritis, in which both vasculitis and antiphospholipid antibodies are frequently present. Treatment of both pathologic processes may be required to prevent progressive tissue ischemia and necrosis. The use of antiplatelet and/or anticoagulation should be given consideration in addition to immunosuppressive agents.
Diabetic muscular infarction.
In the evaluation of patients with a painful atraumatic mass in an extremity, the clinician should consider a number of clinical entities: primary tumor of muscle, focal or localized nodular myositis, local muscular abscess or soft-tissue infection, osteomyelitis, and thrombophlebitis. A rare complication of diabetes, viz, diabetic muscular infarction, heretofore not reported in the rheumatic disease literature is reviewed. This entity is compared with the conditions of focal and localized nodular myositis, which are nearly as rare.